Endocyte Inc. Company Profile

20:29 EDT 17th March 2018 | BioPortfolio

News Articles [30 Associated News Articles listed on BioPortfolio]

Biotech Stocks on Investors' Radar -- Endocyte, Editas Medicine, Halozyme Therapeutics, and Illumina Endocyte On Friday, shares in West Lafayette, Indianaheadquartered Endocyte Inc. recorded a trading volume of 1.11 million shares. The stock ended the sessio...

Endocyte nets $70.5mm through public offering

Endocyte Inc. netted $70.5mm through a public offering of 17.86mm common shares at $4.20. The company is developing targeted cancer therapies, and will use the proceeds to advance its pipeline of radi...

Endocyte nets $81mm through public offering

Endocyte Inc. netted $81mm through a public offering of 20.5mm common shares (including the overallotment) at $4.20. The company is developing targeted cancer therapies, and will use the proceeds to a...

Endocyte's Stunning Strategic Shift

Endocyte's Lu-PSMA-617: Will It Be Lucky This Time

Endocyte Added to NASDAQ Biotechnology Index  

WEST LAFAYETTE, Ind., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment,  today annou...

Endocyte Reports Third Quarter Financial Results

        – Plans to Initiate Phase 3 Registration for 177Lu-PSMA-617 Accelerated by Radiomedix Agreement to Transfer Active U.S. Investigational New Drug Application (IND) to Endocyte – ...

Endocyte Appoints Patrick Machado, J.D. to Its Board of Directors

– Patrick Machado, Co-founder and Former Chief Business and Financial Officer of Medivation, Brings Significant Experience in Building Value in the Prostate Cancer Space – WEST LAFAYETTE, Ind...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Extension Study of EC145 for Subjects Enrolled in a Previous Study With EC145

This extension protocol is for those subjects that have completed the allowed duration of participation in an Endocyte-sponsored clinical trial of EC145 and have continuing evidence of cli...

Companies [4 Associated Companies listed on BioPortfolio]

Endocyte Incorporated

Endocyte, Inc is a biotechnology company focused on vitamin based drug targeting and delivery systems. Vitamins are essential components for specific biological cellular functions. Endocyte's mission ...

Endocyte, Inc.

Endocyte is a privately held biotechnology company with headquarters in the Purdue Research Park of West Lafayette, IN. Based on the applications of Endocyte’s advanced propr...


Endocyte is developing a new generation of receptor-targeted therapeutics or "smart drugs" for the treatment of cancer and autoimmune diseases. Current non-targeted drugs are usually toxic to normal h...

Merck and Endocyte

Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines,...

More Information about "Endocyte Inc." on BioPortfolio

We have published hundreds of Endocyte Inc. news stories on BioPortfolio along with dozens of Endocyte Inc. Clinical Trials and PubMed Articles about Endocyte Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Endocyte Inc. Companies in our database. You can also find out about relevant Endocyte Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record